全球多中心评估:ICU入院时脓毒症与非脓毒症危重患者急性肾损伤恶化或改善对临床结局的影响——来自重症监护国家审计的结果
该研究基于重症监护国家审计数据库,纳入7970例有肌酐和尿量数据的成人ICU患者,排除ICU住院≥2天后发生脓毒症者,按AKIN标准评估入院72小时内及至第7天(出院/死亡前)的AKI。59%患者在ICU入住72小时内符合AKIN的AKI标准;入院时24%有脓毒症,其中68%有AKI,无脓毒症者为57%(p<0.001)。脓毒症组AKIN 3期(40% vs 24%,p<0.001)和肾脏替代治疗(20% vs 5%,p<0.0001)更常见;脓毒症合并AKIN 3期者7天内改善至较低分期的比例低于非脓毒症AKIN 3期者(21% vs 32%,p<0.0001)。住院死亡率与AKI严重程度相关,AKI改善者低于稳定或恶化者,但仍高于无AKI者,即使第7天 apparent 完全恢复。
要点
- ICU入院72小时内59%符合AKIN的AKI标准;入院时脓毒症者AKI占68%,无脓毒症者占57%(p<0.001)。
- 脓毒症组AKIN 3期占40% vs 无脓毒症组24%(p<0.001),肾脏替代治疗占20% vs 5%(p<0.0001)。
- 脓毒症合并AKIN 3期者7天内改善至较低分期者为21%,低于非脓毒症AKIN 3期者的32%(p<0.0001)。
- 住院死亡率随AKI严重程度升高而增加;AKI改善者低于稳定或恶化者,但仍高于无AKI者,即使第7天 apparent 完全恢复。
- 脓毒症与非脓毒症ICU患者的AKI动力学不同,评估肾功能变化需结合脓毒症状态。
适用人群与场景
- 重症监护国家审计数据库中10069例成人ICU患者中有肌酐和尿量数据者纳入本亚研究,共7970例。
- 排除ICU住院≥2天后发生脓毒症的患者。
- 入院时存在或不存在脓毒症的成人ICU患者。
诊断标准与关键阈值
- AKI按急性肾损伤网络(AKIN)标准评估,评估时间窗为入院72小时内及出院/死亡前至第7天。
- AKIN分期用于定义AKI严重程度,包括AKIN 3期。
研究设计与关键结果
- 研究类型为基于重症监护国家审计数据库的多中心评估;纳入7970例成人ICU患者。
- 59%患者在ICU入住72小时内符合AKIN的AKI标准。
- 入院时24%有脓毒症,其中68%有AKI,无脓毒症者为57%(p<0.001)。
- 脓毒症组AKIN 3期占40% vs 无脓毒症组24%(p<0.001);肾脏替代治疗占20% vs 5%(p<0.0001)。
- 脓毒症合并AKIN 3期者7天内改善至较低分期者为21%,非脓毒症AKIN 3期者为32%(p<0.0001)。
- 住院死亡率与AKI严重程度相关,AKI改善者低于稳定或恶化者,但仍高于无AKI者,即使第7天 apparent 完全恢复。
证据类型、等级与局限
- 证据类型:基于重症监护国家审计数据库的多中心评估。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在ICU床旁评估AKI时,应结合入院时脓毒症状态判断肾功能变化趋势:脓毒症患者AKI更重且7天内改善率更低。
- 即使第7天 apparent 完全恢复,既往AKI患者的住院死亡率仍高于无AKI者,出院前需结合AKI病史评估风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute kidney injury (AKI) is a common complication of critical illness and is associated with worse outcomes. However, the influence of deterioration or improvement in renal function on clinical outcomes is unclear. Using a large international database, we evaluated the prevalence and evolution of AKI over a 7-day period and its effects on clinical outcomes in septic and non-septic critically ill patients worldwide.
METHODS: From the 10,069 adult intensive care unit (ICU) patients in the Intensive Care Over Nations database, all those with creatinine and urine output data were included in this substudy. Patients who developed sepsis during the ICU stay (≥ 2 days after admission) were excluded. AKI was evaluated within 72 hours after admission and before discharge/death up to day 7 according to the Acute Kidney Injury Network (AKIN) criteria.
RESULTS: A total of 7970 patients were included, 59% of whom met AKIN criteria for AKI within the first 72 hours of the ICU stay. Twenty-four per cent of patients had sepsis on admission, of whom 68% had AKI, compared to 57% of those without sepsis on admission (p < 0.001). AKIN stage 3 (40% vs 24%, p < 0.001) and use of renal replacement therapy (20% vs 5%, p < 0.0001) were more prevalent in patients with sepsis. Patients with sepsis and AKIN stage 3 were less likely to improve to a lower stage during the 7-day follow-up period than non-septic patients with AKIN stage 3 (21% vs 32%, p < 0.0001). In-hospital mortality was related to severity of AKI and was reduced in patients in whom AKI improved compared to those who remained stable or deteriorated, but remained higher than in patients without AKI, even if there was apparent full recovery at day 7.
CONCLUSION: These findings illustrate the different kinetics of AKI in septic and non-septic ICU patients and emphasize the important impact of AKI on mortality rates even when there is apparent full renal recovery at day 7.
参考来源
- Peters E, Antonelli M, Wittebole X, et al. A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit. Crit Care. 2018. PMID: 30075798. doi:10.1186/s13054-018-2112-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。